1.7 mg Wegovy: Understanding This Dose Stage

Wegovy is a once-weekly injectable medicine containing semaglutide, a GLP-1 receptor agonist. According to the electronic Medicines Compendium (eMC), the titration schedule typically moves through a series of increasing strengths: the starting 0.25 mg stage, then 0.5 mg, then 1 mg, then 1.7 mg, before reaching the 2.4 mg dose that most people remain on long term.

Why doses increase gradually

The step-up approach is designed to help the body adjust to semaglutide over time. Starting at a low dose and moving upward — always under prescriber guidance — is the standard approach for this class of medicine. The timing of each increase, and whether a step is held for longer or adjusted, is a decision that belongs entirely with your prescriber or doctor. No two journeys are identical.

The doses in context

• 0.25 mg — the initial starting strength
• 0.5 mg — the first increase
• 1 mg (1.0 mg) — the third stage
• 1.7 mg — the fourth stage, the focus of this page
• 2.4 mg — the intended maintenance dose for most people

You may sometimes see 1.7 mg referred to informally as "1.7" or encounter queries around figures like "7.2 mg" or "5 mg Wegovy" — these do not correspond to the approved Wegovy dose strengths. The confirmed dose stages above are the ones referenced in the product information. If you have any questions about your specific prescription, always check with your prescriber or pharmacist rather than relying on informal sources.

For context on how Wegovy compares to tirzepatide-based treatment, the page on the early Mounjaro dose stages gives a useful overview of how GLP-1 titration works across different medicines.

Keeping a clear record of every dose becomes especially important during titration, when your schedule is actively changing. GLP Trackr's dose logging feature lets you record each weekly injection — the dose strength, date, and time — so you always have an accurate history of where you are in your journey.

If you ever miss a dose or are unsure what to do next, the app helps you log that too, giving you a clear record to bring to your prescriber. Any decision about a missed dose or schedule change must be made with your prescriber or doctor — GLP Trackr records the information so you can have an informed conversation, but it is not a substitute for their guidance.

Alongside dose logging, the app's reminder feature means your weekly injection day is never forgotten, and the insights tools help you see how your journey is progressing week by week — useful context to share at your next prescriber appointment.

You can also explore more detail on the 1.7 mg Wegovy stage or read about managing your GLP-1 treatment schedule for broader context on staying consistent through titration.

Always follow the guidance of your prescriber or doctor — they know your full medical history and are best placed to advise on your dose schedule. If you experience anything severe, persistent, or worrying at any stage of your treatment, contact your healthcare professional promptly. Any side effects worth noting can also be reported to your national reporting scheme (such as the UK's Yellow Card scheme) in addition to telling your prescriber.

Ready to keep your weekly dose schedule on track? Download GLP Trackr on the App Store or Google Play and start a free 7-day trial — log every injection, set reminders, and build a clear record of your Wegovy journey.